EKF Diagnostics Holdings plc announced that Julian Baines, Chief Executive Officer, has notified the Board of his intention to step down from his current position with effect from 1 October 2021. In the period to 1 October, Julian will be supporting his successor, Mike Salter, the current head of the Group's US operations, who will assume the role of Chief Executive Officer of EKF from the same date. Mike Salter is the President of EKF Diagnostics' American business where he is responsible for all USA facilities including sales, operations and Regulatory Affairs, and also has a particular focus on EKF Life Sciences in Elkhart, Indiana. Previously, Mike worked at GE Healthcare where he was General Manager for the Custom Molecular Reagent Business within GE Life Sciences. Mike has over 35 years of experience in the Life Science and Diagnostics Industry, 33 of which were spent with GE and Amersham in a variety of positions in the UK, Canada and USA.